Globeflex Capital’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Globeflex Capital’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-58,611	Closed	-$187K	–	551
2022 Q2	$187K	Sell	58,611 -34,188	-37%	-$133K	0.05%	325
2022 Q1	$396K	Hold	92,799	–	–	0.08%	268
2021 Q4	$432K	Buy	92,799 +65,710	+243%	+$274K	0.09%	256
2021 Q3	$108K	Buy	+27,089	New	+$108K	0.02%	387

Globeflex Capital's LJPC Position: Q3 2022 in Review

Globeflex Capital sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2022, closing a stake of 58,611 shares — an estimated $187K sold.

Globeflex Capital first reported a position in LJPC in Q3 2021 and held it in 4 quarters. The position peaked at $432K in Q4 2021. 0 funds tracked by Wall St. Rank hold LJPC as of Q3 2022.

Globeflex Capital reported no remaining La Jolla Pharmaceutical Company position as of Q3 2022 after selling out during the quarter.
Globeflex Capital sold 58,611 La Jolla Pharmaceutical Company shares in Q3 2022, an estimated $187K.
Globeflex Capital first reported a position in La Jolla Pharmaceutical Company in Q3 2021 and held it in 4 quarters.
Globeflex Capital's La Jolla Pharmaceutical Company position peaked at $432K in Q4 2021.
0 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2022.

Based on Globeflex Capital's 13F filing for Q3 2022, filed 14 Nov 2022.